InvestorsHub Logo
Followers 829
Posts 119605
Boards Moderated 14
Alias Born 09/05/2002

Re: None

Monday, 05/11/2020 11:36:56 AM

Monday, May 11, 2020 11:36:56 AM

Post# of 1162
BMY pays BLUE $200M lump-sum in lieu of future royalties on ide-cel and bb21217 BCMA CAR-T therapies:

https://finance.yahoo.com/news/bluebird-bio-announces-amended-bcma-113500670.html

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BMY News